A recent study has reported that defects in a nuclear receptor located in the brain could be linked to autism spectrum disorders.
Browsing: autism spectrum disorders
Balovaptan, a molecule being developed by Roche for autism spectrum disorder, has been given FDA approval in order to accelerate its development.
New research has shed light on why autism is more common in men than women.
Individuals with autism may demonstrate impairment of the sensory motor controls within their cerebellum.
Researchers have used MRI scans to predict risk of developing autism in infants long before symptoms occur – autism was correctly predicted in 80% of infants.
In this interview, we speak to Elena Minakova, a Fellow in Neonatology at UCLA who is investigating a role for Melanotan-II in reducing social deficits in autism.
Relationship elucidated between genes associated with psychiatric disorders and social communication
Researchers have discovered that psychiatric disorders share some genetic influences with social communication problems and that these genetic links have disorder-dependent developmental profiles.
The authors review how dysregulation of histone methylation has emerged as a major driver of neurodevelopmental disorders such as intellectual disabilities and autism spectrum disorders.
A new study has demonstrated a distinctive pattern of unusual gene activity in the brains of autistic individuals; a finding that indicates several possible new drug targets.
In this report the authors discuss the role of the endogenous cannabinoid system in autism spectrum disorders and the potential for targeting this as a therapeutic strategy,